According to the study, sex, age, and severity of the disease may serve as useful markers for the selection of COVID-19 survivors as convalescent plasma donors
An international team of researchers has developed two molecules to inhibit the function of a cell 'cutting' enzyme in the SARS-CoV-2 coronavirus that causes COVID-19
The study found that people born with congenital heart disease may be at a lower risk of moderate and severe outcomes of the SARS-CoV-2 coronavirus infection
Scientists from the University of Southampton have developed a test that can identify patients with SARS-CoV-2 coronavirus infection who are at a higher risk of cytokine storms